IE831259L - Polyfluorinated alcohol-containing composition. - Google Patents

Polyfluorinated alcohol-containing composition.

Info

Publication number
IE831259L
IE831259L IE831259A IE125983A IE831259L IE 831259 L IE831259 L IE 831259L IE 831259 A IE831259 A IE 831259A IE 125983 A IE125983 A IE 125983A IE 831259 L IE831259 L IE 831259L
Authority
IE
Ireland
Prior art keywords
containing composition
polyfluorinated alcohol
component
polyfluorinated
alcohol
Prior art date
Application number
IE831259A
Other versions
IE55137B1 (en
Original Assignee
Fcn Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fcn Srl filed Critical Fcn Srl
Publication of IE831259L publication Critical patent/IE831259L/en
Publication of IE55137B1 publication Critical patent/IE55137B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/34—Halogenated alcohols
    • C07C31/38—Halogenated alcohols containing only fluorine as halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pharmaceutical compositions having antineoplastic activity comprise as the active ingredient component a) which is at least one polyfluoroalcohol of formula I: CHF2-(CF2)n-CH2OH (I> wherein n is 3, 5, 7 or 9; and optionally component b) cholesterol. Preferably the compositions containing two and still better at least three polyfluoroalcohols. A lipophilic solvent may be present, for instance sesame oil. [GB2121280A]
IE1259/83A 1982-05-28 1983-05-27 Pharmaceutical compositions containing at least one polyfluorinated alcohol IE55137B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8221553A IT8221553A0 (en) 1982-05-28 1982-05-28 PHARMACEUTICAL COMPOSITIONS ANTINEOPLASTIC ADAPTIVITY.

Publications (2)

Publication Number Publication Date
IE831259L true IE831259L (en) 1983-11-28
IE55137B1 IE55137B1 (en) 1990-06-06

Family

ID=11183507

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1259/83A IE55137B1 (en) 1982-05-28 1983-05-27 Pharmaceutical compositions containing at least one polyfluorinated alcohol

Country Status (16)

Country Link
JP (1) JPS591414A (en)
AU (2) AU552557B2 (en)
BE (1) BE896838A (en)
CH (1) CH653890A5 (en)
DE (1) DE3319304A1 (en)
FR (1) FR2527439A1 (en)
GB (1) GB2121280B (en)
IE (1) IE55137B1 (en)
IL (1) IL68796A0 (en)
IN (1) IN157042B (en)
IT (1) IT8221553A0 (en)
LU (1) LU84827A1 (en)
NL (1) NL8301899A (en)
NZ (1) NZ204393A (en)
SE (1) SE8302976L (en)
ZA (1) ZA833871B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3836971C1 (en) * 1988-10-31 1990-05-17 Weck, Wolfgang, Dr.Med., 6990 Bad Mergentheim, De

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3219004C1 (en) * 1982-05-19 1984-03-01 Philippine Dr. 8000 München Hartmann Pharmaceutical compositions for the treatment of tumours

Also Published As

Publication number Publication date
GB2121280B (en) 1985-08-29
GB2121280A (en) 1983-12-21
AU1500083A (en) 1983-12-01
NL8301899A (en) 1983-12-16
IN157042B (en) 1986-01-04
IE55137B1 (en) 1990-06-06
AU552557B2 (en) 1986-06-05
IT8221553A0 (en) 1982-05-28
JPS591414A (en) 1984-01-06
GB8314540D0 (en) 1983-06-29
BE896838A (en) 1983-09-16
SE8302976L (en) 1983-11-29
NZ204393A (en) 1986-03-14
SE8302976D0 (en) 1983-05-26
IL68796A0 (en) 1983-09-30
DE3319304A1 (en) 1983-12-01
FR2527439A1 (en) 1983-12-02
CH653890A5 (en) 1986-01-31
LU84827A1 (en) 1983-11-17
ZA833871B (en) 1984-07-25
AU1557088A (en) 1988-11-10

Similar Documents

Publication Publication Date Title
ATE53301T1 (en) SYSTEMS FOR IMPROVING PERFORMANCE AND THEIR PREPARATION.
IE812075L (en) Composition
CA2031384A1 (en) Active component concentrates and new active component combinations from ginkgo biloba leaves, their method of preparation and pharmaceuticals containing the active component concentrates or the active component combinations
CA2009735A1 (en) Insecticidally active nitro compounds
IE820137L (en) Phosphoryl compounds
MY101847A (en) Composition for solid pharmaceutical preparations of active vitamins d 3 and process for preparation thereof.
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
AU7227587A (en) Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
EP0957093A3 (en) Retrovial protease inhibitors
IT8519189A0 (en) PROCEDURE FOR THE PREPARATION OF VANADIUM COMPOUNDS FROM VANADIUM-CONTAINING RESIDUES.
AU6168190A (en) Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient
IL105646A0 (en) Sulfonylbenzyl-substituted benzo-and pyridopyridones,their preparation and pharmaceutical compositions containing them
EP0173664A3 (en) Biologically active benzimidazole compounds and process for their preparation
WO1998010786A3 (en) Pharmaceutical composition for the treatment of syndrome x of reaven
ES2002631A6 (en) Oil-in-water pesticidal emulsion
EP0031584A3 (en) 2-substituted-aminopropene- and propanenitrile compounds and antimicrobial and pharmaceutical, anti-inflammatory compositions
IE831259L (en) Polyfluorinated alcohol-containing composition.
ZA935865B (en) 17-(3-furyl) and 17-(4-pyridazinyl)-5Béta 14Béta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same
CA2150244A1 (en) Chlorofluoroether Compositions and Preparation Thereof
KR900003174A (en) Benzofuro [3,2-C] quinoline compound
IE821319L (en) Nematocidal compositions
AU590443B2 (en) 2,3,4,5,6,7,-hexahydro-2,7-methano-1,5-benzoxazonine and -1,4-benzoxazonine compounds, processes for their preparation, and pharmaceutical compositions containing them
IE810760L (en) Thiazoles
EP0239527A3 (en) Composition adopted for use as a transdermal formulation
EP0056681A3 (en) Levonantradol and n-methyllevonantradol formulations